• English
    • svenska
  • svenska 
    • English
    • svenska
  • Logga in
Redigera dokument 
  •   Startsida
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Clinical Sciences / Institutionen för kliniska vetenskaper
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • Redigera dokument
  •   Startsida
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Clinical Sciences / Institutionen för kliniska vetenskaper
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • Redigera dokument
JavaScript is disabled for your browser. Some features of this site may not work without it.

Expression of Tissue Antigens in Human Pluripotent Stem Cells and Alterations During Differentiation

Potential application in regenerative medicine for treatment of terminal cell and organ failure

Sammanfattning
The major limiting factor in the treatment of patients with end-stage organ failure is the insufficient number of human organs available for transplantation. An unlimited access to human cells, tissues and organs would also open up possibilities to treat several chronic diseases, such as diabetes, neurological and cardiovascular diseases, affecting millions of patients worldwide. Cells and tissues derived from human pluripotent stem cells (hPSC) could potentially fulfill these ambitions. However, there are several biomedical barriers to overcome before this can be a clinical reality. One of the most important concerns is the immunogenicity of the conceivable cell or tissue grafts derived from hPSC when exposed to a non-self recipient. This thesis explores the expression of immunogenic tissue HLA and blood group antigens in several hPSC cell lines and their derivatives. This characterization was performed by several complementary analytical techniques, such as flow cytometry, immunohistochemistry, PCR, as well as biochemical characterization of glycosphingolipid molecular structures and protein bound antigen composition. The results demonstrate that pluripotent stem cells express various cell surface immunodeterminants including HLA, AB(O)H and related histo-blood group antigens. Moreover, we identified significant alterations of antigen expression patterns during endodermal, mesodermal and ectodermal differentiation. Consequently, our results indicate that all hPSC-derived cells intended for clinical applications should be characterized regarding their individual tissue antigen profile in accordance with the standard selection criteria used in allotransplantation. Furthermore, we identified a novel cell surface marker of undifferentiated stem cells, sialyl-lactotetra, which can be used as a verification and selection tool for pluripotency, as well as a potential exclusion measure in heterogeneously differentiated cell cultures to prevent tumor formation. In conclusion, this thesis adds new knowledge regarding cell surface antigen expression in hPSC of relevance both for basic science and for future clinical applications within transplantation and regenerative medicine.
Delarbeten
Paper I. I. Barone A, Säljö K, Benktander J, Blomqvist M, Månsson JE, Johansson BR, Mölne J, Aspegren A, Björquist P, Breimer ME, Teneberg S. Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells. Journal of Biological Chemistry 2014; 289, 18846-18859 ::doi::10.1074/jbc.M114.568832
 
Paper II. Säljö K, Barone B, Vizlin-Hodzic D, Johansson BR, Breimer ME, Funa K, Teneberg S. Comparison of the glycosphingolipids of human-induced pluripotent stem cells and human embryonic stem cells. Glycobiology 2017; 27: 291-305. ::doi::10.1093/glycob/cww125
 
Paper III. Säljö K, Barone A, Mölne J, Rydberg L, Teneberg S, Breimer ME. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives. Manuscript, submitted
 
Examinationsnivå
Doctor of Philosophy (Medicine)
Universitet
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clincial Sciences. Department of Surgery
Disputation
Fredagen den 16 juni 2017, kl 9.00, Hörsal Arvid Karlsson, Academicum, Medicinaregatan 3, Göteborg
Datum för disputation
2017-06-16
E-post
karin.saljo@vgregion.se
URL:
http://hdl.handle.net/2077/51884
Samlingar
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • Doctoral Theses from Sahlgrenska Academy
  • Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Fil(er)
Thesis frame (18.43Mb)
Abstract (197.0Kb)
Cover (2.027Mb)
Datum
2017-05-24
Författare
Karin, Säljö
Nyckelord
Pluripotent stem cells
Differentiation
Histo-blood group antigens
HLA
Tissue antigens
Sialyl-lactotetra
Cell surface antigens
Transplantation
Regenerative medicine
Publikationstyp
Doctoral thesis
ISBN
978-91-629-0217-9 (Print)
978-91-929-0218-6 (Pdf)
Språk
eng
Metadata
Visa fullständig post

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV
 

 

Visa

VisaSamlingarI datumordningFörfattareTitlarNyckelordDenna samlingI datumordningFörfattareTitlarNyckelord

Mitt konto

Logga inRegistrera dig

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV